Courtney Martinez
Acute Care · Kingwood, TXNPI 1518394923
Payments from drug & device makers
Across 54 payments — averaging $27.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$228
- Novartis$228
- Amgen$216
- Cvrx, Inc.$158
- Merck$89
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$74
- plus $498 from 17 others
What the payments were for
- Food & beverage$1,491100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 3 | $228 |
| Novartis | 11 | $228 |
| Amgen | 6 | $216 |
| Cvrx, Inc. | 1 | $158 |
| Merck | 5 | $89 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $74 |
| Medtronic | 3 | $63 |
| Esperion Therapeutics, Inc. | 4 | $59 |
| Johnson & Johnson | 2 | $43 |
| Bayer | 2 | $41 |
| Novo Nordisk | 2 | $34 |
| AstraZeneca | 2 | $28 |
| Regeneron | 1 | $27 |
| Bridgebio Pharma, Inc. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Impulse Dynamics (USA) Inc. | 1 | $23 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $23 |
| Pfizer | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| GSK | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$158
- Repatha$114
- ENSITE$112
How this compares
$1,491 in reported general payments places this provider in the 75th percentile of 2,323 acute care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 90 | $95,190 |
| Repatha SureclickEvolocumab | 28 | $25,733 |
| XareltoRivaroxaban | 15 | $25,096 |
| JardianceEmpagliflozin | 30 | $23,291 |
| EntrestoSacubitril/Valsartan | 30 | $21,433 |
| BrilintaTicagrelor | 11 | $5,625 |
| Clonidine | 17 | $3,101 |
| Ranolazine ErRanolazine | 17 | $2,914 |
| Metoprolol Succinate | 143 | $2,436 |
| Nifedipine ErNifedipine | 37 | $1,529 |
| Hydralazine Hcl | 76 | $1,070 |
| Atorvastatin Calcium | 84 | $1,047 |
| Propafenone Hcl | 20 | $979 |
| Rosuvastatin Calcium | 73 | $876 |
| Ezetimibe | 23 | $864 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $20 | $95,19090 claims |
| Johnson & JohnsonXarelto | $43 | $25,09615 claims |
| Boehringer IngelheimJardiance | $20 | $23,29130 claims |
| NovartisEntresto | $228 | $21,43330 claims |
| AstraZenecaBrilinta | $28 | $5,62511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,323 acute care providers in Texas.
Other acute care in Kingwood
- Jennifer PilotteDallas$232K
- Christie MorrisonSan Antonio$225K
- Amanda BradleyDallas$85K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
- Martha LibertyDallas$28K
- Afton DickersonHouston$27K
- Eleanor WeltgeHouston$25K
- Leslie GutierrezHouston$25K
- Bahia ElkamandSugar Land$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.